Drug intelligence / Profile preview

docosahexaenoic acid + vitamin D3

Development stage
Unknown
Administration
Oral
01

Overview

Docosahexaenoic acid (DHA) and vitamin D3 is a nutritional supplement combination that has been studied for various health benefits. This combination has shown promising results in clinical trials, particularly for non-alcoholic fatty liver disease (NAFLD) in obese children with vitamin D deficiency. DHA is an omega-3 fatty acid found in cold-water fish like tuna and salmon. It plays a crucial role in the development of eye and nerve tissues and may reduce the risk of cardiovascular disease by decreasing blood thickness, reducing inflammation, and lowering triglyceride levels[3]. Vitamin D3 (cholecalciferol) is a fat-soluble vitamin that promotes calcium absorption, supporting bone health and immune function[5]. When combined, these nutrients have shown synergistic effects. In a randomized, double-blind placebo-controlled trial, DHA (500 mg) plus vitamin D (800 IU) treatment in obese children with biopsy-proven NAFLD and vitamin D deficiency resulted in: - Reduced NAFLD Activity Score (NAS) - Improved insulin resistance - Better lipid profiles - Decreased ALT levels - Reduced activation of hepatic stellate cells and fibrillar collagen content[1] The combination has been studied in several clinical trials: 1. A study of obese children with biopsy-proven NAFLD showed significant improvements in liver histology and metabolic parameters after 12 months of treatment with 500 mg DHA plus 800 IU vitamin D daily[1]. 2. Another multicenter, randomized, double-blind controlled study investigated the effect of vitamin D and DHA co-supplementation for six months on vitamin D status, body composition, and metabolic markers in obese children with vitamin D deficiency. While both groups showed improvement in vitamin D status, the DHA plus vitamin D group had higher increases in DHA levels, which could be relevant for preventing inflammatory complications of obesity[2]. 3. Recent research has also explored the combination with probiotics, showing benefits against aluminum-induced cognitive impairment[4]. This combination is primarily used as a nutritional supplement to: - Support cardiovascular health - Promote cognitive development and function - Enhance bone health - Strengthen the immune system - Manage nutritional deficiencies[5] It's often found in combination with other nutrients like methylfolate, methylcobalamin, and pyridoxal-5-phosphate in various formulations[5][6]. Potential side effects may include: - Gastrointestinal discomfort - Allergic reactions - Skin sensitivity - Mild nausea - Dizziness[5] DHA may interact with certain medications: - Antihypertensive drugs (may cause blood pressure to go too low) - Anticoagulants/antiplatelet drugs (may increase risk of bruising and bleeding) - Antidiabetic medications (may affect blood sugar levels)[3][5] This nutritional supplement combination represents a promising approach for addressing various health conditions, particularly those related to inflammation, metabolic disorders, and nutritional deficiencies.

Other names
DHA + vitamin DVitamin D + DHA
02

Targets

PPAR (PPAR family)RXRA (Retinoid X receptor alpha)VDR (Vitamin D receptor)

Beyond the preview

Go deeper on docosahexaenoic acid + vitamin D3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on docosahexaenoic acid + vitamin D3.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call